Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
09/2014
09/25/2014WO2014152768A1 Cyclohexanediamine compounds and methods for their preparation
09/25/2014WO2014152716A1 Substituted heterocyclic compounds for treating or preventing viral infections
09/25/2014WO2014151616A1 Biaryl amide compounds as kinase inhibitors
09/25/2014WO2014150677A1 Inhibitors of indoleamine 2,3-dioxygenase (ido)
09/25/2014WO2014146581A1 Method for preparing acrylate compound
09/25/2014US20140288106 Cycloalkane carboxylic acid derivatives as cxcr3 receptor antagonists
09/25/2014US20140288092 Heteroaryl compounds as sodium channel blockers
09/25/2014US20140288067 Carm1 inhibitors and uses thereof
09/25/2014US20140288049 2-Thiopyrimidinones
09/25/2014US20140288040 Substituted benzylamine compounds, their use in medicine, and in particular the treatment of hepatitis c virus (hcv) infection
09/25/2014US20140288017 Catechol diethers as potent anti-hiv agents
09/24/2014EP2781510A1 HIV inhibiting 5,6-substituted pyrimidines
09/23/2014US8841483 Compositions useful as inhibitors of voltage-gated sodium channels
09/23/2014US8841447 Process for the preparation of alogliptin
09/23/2014US8841315 Inhibitors of protein kinases
09/23/2014US8841314 2-Thiopyrimidinones
09/23/2014US8841313 CCR2 antagonists and uses thereof
09/23/2014US8841311 Sulphone-substituted quinazoline derivatives as immuno-modulators, their preparation and use as medicaments
09/23/2014US8841295 5-lipoxygenase-activating protein (FLAP) inhibitors
09/23/2014CA2596393C 4-(benzyl)-piperazine-1-carboxylic acid phenylamide derivatives and related compounds as modulators of fatty acid amide hydrolase for the treatment of anxiety, pain and other conditions
09/18/2014WO2014145807A1 Process for the preparation of 4-amino-1-((1s,4r, 5s)-2-fluoro-4,5-dihydroxy-3-hydroxymethyl-cyclopent-2-enyl)-1h-pyrimidin-2-one
09/18/2014WO2014145004A1 Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities
09/18/2014WO2014144169A1 Carm1 inhibitors and uses thereof
09/18/2014WO2014142255A1 Heterocyclic compound
09/18/2014WO2014140246A1 Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine d3 receptor
09/18/2014WO2014139489A1 Method for the preparation of ticagrelor and intermediates suitable therefore
09/18/2014WO2014139465A1 Novel pyrimidine and pyridine compounds and their usage
09/18/2014WO2014139087A1 Racemization method of chiral 2-[(4,6-dimethylpyrimidine-2-yl)oxy]-3-methoxy-3,3-diphenyl propionic acid
09/18/2014WO2014139086A1 Method for preparing ambrisentan
09/18/2014WO2013164337A9 Pyrimidine derivatives for the treatment of bacterial diseases
09/18/2014US20140275711 1-(Arylmethyl)-5,6,7,8-tetrahydroquinazolline-2,4-diones and Analogs and the Use Thereof
09/18/2014US20140275538 Rilpivirine process
09/18/2014US20140275537 Process for the preparation of 4-amino-1-((1s,4r,5s)-2-fluoro-4,5-dihydroxy-3-hydroxymethyl-cyclopent-2-enyl)-1h-pyrimidin-2-one
09/18/2014US20140275535 Acid addition salts of bosentan
09/18/2014US20140275534 Method for preparing 1-(4-(4-(3,4-dichloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yloxy) piperidin-1-yl)-prop-2-en-1-one hydrochloride and intermediates used therein
09/18/2014US20140275508 Artificial nucleic acids
09/18/2014US20140275134 Meldrum's acid, barbituric acid and pyrazolone derivatives substituted with hydroxylamine as hno donors
09/18/2014US20140275104 Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine d3 receptor
09/18/2014US20140275093 Substituted hydroxamic acids and uses thereof
09/18/2014US20140275088 Small molecule malarial aldolase-trap enhancers and glideosome inhibitors
09/18/2014US20140275060 Compounds for the treatment of neurologic disorders
09/18/2014US20140275043 Substituted 3-phenylpropylamine derivatives for the treatment of ophthalmic diseases and disorders
09/18/2014US20140275003 Biaryl amide compounds as kinase inhibitors
09/17/2014EP2776406A2 Erlotinib salts
09/17/2014EP2776405A1 2-thiopyrimidinones
09/17/2014EP2776404A1 Heterocyclic analogs of propargyl-linked inhibitors of dihydrofolate reductase
09/17/2014EP2776402A1 Meldrum 's acid, barbituric acid and pyrazolone derivatives substituted with hydroxylamine as hno donors
09/17/2014EP2776387A1 Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction
09/16/2014US8835630 Acyclic nucleoside phosphonate diesters
09/16/2014US8835491 Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance
09/16/2014US8835472 Compounds, pharmaceutical compositions and uses thereof
09/16/2014US8835461 Substituted 3-hydroxy-4-pyridone derivative
09/16/2014US8835458 Quinoline or quinazoline derivatives with apoptosis inducing activity on cells
09/16/2014US8835449 2-thiopyrimidinones
09/16/2014US8835446 Quinazoline derivatives and pharmaceutical compositions thereof
09/16/2014US8835445 Dihydrofolate reductase inhibitors
09/16/2014US8835443 Pyrimidine compound and medical use thereof
09/16/2014US8835440 Cyclic pyrimidin-4-carboxamides as CCR2 receptor antagonists for treatment of inflammation, asthma and COPD
09/16/2014US8835437 Piperidine/piperazine derivatives
09/16/2014US8835434 Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors
09/16/2014US8835430 2,4-pyrimidinediamine compounds and their uses
09/16/2014US8835426 Cyclic urea and carbamate inhibitors of 11β-hydroxysteroid dehydrogenase 1
09/16/2014US8835418 Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application
09/16/2014CA2725052C Preparation method of rosuvastatin calcium and its intermediates
09/12/2014WO2014138302A1 Quinazolinone antibiotics
09/12/2014WO2014138053A1 Neprilysin inhibitors
09/12/2014WO2014135955A1 Pyrimidine carboxamides as sodium channel blockers
09/12/2014WO2014135414A1 Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
09/11/2014US20140256759 Kinase inhibitor and method for treatment of related diseases
09/11/2014US20140256754 Quinazolines as b-glucuronidase novel inhibitors
09/11/2014US20140256753 Quinazolinone analogs and use of quinazolinone analogs for treating or preventing certain viral infections
09/11/2014US20140256747 Synthesis of Triazolopyrimidine Compounds
09/11/2014US20140256743 Cathepsin cysteine protease inhibitors
09/11/2014US20140256691 Combinations of akt inhibitor compounds and abiraterone, and methods of use
09/11/2014US20140256004 Process for the Preparation of an Endothelin Receptor Antagonist
09/10/2014EP2774609A1 Pharmaceutical compositions comprising a HMG COA reductase inhibitor
09/10/2014EP2773623A1 1-(arylmethyl)-5,6,7,8-tetrahydroquinazoline-2,4-diones and analogs and the use thereof
09/10/2014EP2773622A1 Pesticidal compounds
09/10/2014EP2773616A1 Pesticidal compounds
09/10/2014EP2773615A1 Pharmaceutical compounds
09/09/2014US8829209 Cycloalkylcarbonylamino acid ester derivative and process for producing the same
09/09/2014US8829015 Crystalline forms of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide
09/09/2014US8829007 Inhibitors of influenza viruses replication
09/09/2014US8829006 Compounds
09/09/2014US8828999 Pyrimidine compounds and their uses
09/09/2014US8828991 Azacyclyl-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments
09/09/2014US8828982 Pyrimidine derivatives for the prevention of HIV infection
09/04/2014US20140249309 Method for Preparing Optically Pure (+)-Ambrisentan and (+)-Darusentan
09/04/2014US20140249163 Malignant and non-malignant disease treatment with ras antagonists
09/04/2014US20140249151 Bicyclic heterocyclic compound
09/04/2014US20140249139 Quinazoline Derivatives
09/04/2014US20140249129 Substituted Bicyclic Dihydropyrimidinones And Their Use As Inhibitors Of Neutrophil Elastase Activity
09/04/2014US20140248378 Pyrimidinone compounds and their use
09/04/2014US20140248299 Vinyl-phenyl derivatives for inflammation and immune-related uses
09/04/2014US20140248236 Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction
09/03/2014EP2772486A1 Kinase inhibitor and method for treatment of related diseases
09/03/2014EP2771326A1 Synthesis of triazolopyrimidine compounds
09/03/2014EP2771322A2 Novel trpv3 modulators
09/02/2014US8822685 2,4-pyrimidinediamine compounds and their uses
09/02/2014US8822467 Biaryl oxyacetic acid compounds
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 ... 427